Filing Details

Accession Number:
0001209191-22-048534
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-09-02 17:12:05
Reporting Period:
2022-09-01
Accepted Time:
2022-09-02 17:12:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1637715 Reneo Pharmaceuticals Inc. RPHM Pharmaceutical Preparations (2834) 472309515
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1854179 Michael Cruse C/O Reneo Pharmaceuticals, Inc.
18575 Jamboree Road, Suite 275-S
Irvine CA 92612
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-09-01 7,500 $3.39 13,697 No 4 P Indirect by Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect by Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 31,758 Direct
Footnotes
  1. The weighted average purchase price for the transaction was $3.393. The shares were purchased at a range of prices between $3.36 and $3.48. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
  2. By Michael P. Cruse and Thu Anh Thuy Cruse, Trustees of The Cruse Family Revocable Living Trust.